YOD-RiSoCo: Social Cognition and Risk-taking Behaviour in Patients with Young-onset Dementia

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-70
SponsorUniversity Medical Center Groningen

About this trial

The goal of this observational study is to learn about social cognition and risky behaviour in patients with young-onset dementia (YOD). The investigators want to

* Examine differences in performance on social cognition test and measures of risky behaviour between behavioural variant YOD patients, patients with frontal brain injury, non-behavioural YOD patients and healthy controls. * Examine if there is a relation between social cognition tests and measures of risky behaviour.

Participants will be administered a neuropsychological assessment including social cognition measures and patients will complete a driving simulator task in which risky behaviour will be elicited.

Eligibility criteria

Qualifiers

Sufficient command of the Dutch language

In possession of a driver's license with any driving experience throughout life

Age 18 to 65

Probable diagnosis of young-onset dementia (before 65 years old), confirmed after interdisciplinary consensus meeting in which interviews, neuropsychological examination, neurological and psychiatric assessments, neuro-imaging, blood samples, and in some cases FDG/PIB-PETscans, CSF biomarkers or genetic counseling were discussed.

Disqualifiers

Suffering from severe motion sickness; motion sickness is a risk factor for simulator sickness

Presence of serious psychiatric disorders

History of neurological disorders, which may interfere with cognitive functioning (e.g. recent concussion, previous subarachnoid or intracerebral haemorrhage, intracranial tumours, epilepsy, ischemic stroke).

Trial design

Treatments tested in this trial

  • Neuropsychological assessment, driving simulator task

Treatment groups

140 Participants
are divided into 4 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

University Medical Center Groningen

Lead sponsor

ZonMw: The Netherlands Organisation for Health Research and Development

Collaborator